vs
Side-by-side financial comparison of bioAffinity Technologies, Inc. (BIAF) and Laser Photonics Corp (LASE). Click either name above to swap in a different company.
bioAffinity Technologies, Inc. is the larger business by last-quarter revenue ($1.6M vs $919.3K, roughly 1.7× Laser Photonics Corp). bioAffinity Technologies, Inc. runs the higher net margin — -197.0% vs -506.4%, a 309.5% gap on every dollar of revenue. On growth, Laser Photonics Corp posted the faster year-over-year revenue change (28.3% vs -27.8%). Over the past eight quarters, Laser Photonics Corp's revenue compounded faster (-3.9% CAGR vs -18.6%).
bioAffinity Technologies, Inc. is a clinical-stage biotechnology firm focused on developing non-invasive in vitro diagnostic tests for early detection of cancer and respiratory diseases. It serves global healthcare markets, with a core mission to deliver accessible, high-accuracy diagnostic solutions that improve patient outcomes and reduce overall healthcare system costs.
IPG Photonics Corporation is a manufacturer of fiber lasers. IPG Photonics developed and commercialized optical fiber lasers, which are used in a variety of applications including materials processing, medical applications and telecommunications. IPG has manufacturing facilities in the United States, Germany, Russia and Italy.
BIAF vs LASE — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | ||
|---|---|---|
| Revenue | $1.6M | $919.3K |
| Net Profit | $-3.1M | $-4.7M |
| Gross Margin | — | -20.1% |
| Operating Margin | -196.9% | -350.0% |
| Net Margin | -197.0% | -506.4% |
| Revenue YoY | -27.8% | 28.3% |
| Net Profit YoY | -5.7% | -186.5% |
| EPS (diluted) | $-3.59 | $-0.27 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.6M | — | ||
| Q3 25 | $1.4M | $919.3K | ||
| Q2 25 | $1.3M | $2.6M | ||
| Q1 25 | $1.9M | $2.3M | ||
| Q4 24 | $2.2M | $1.3M | ||
| Q3 24 | $2.4M | $716.7K | ||
| Q2 24 | $2.4M | $623.4K | ||
| Q1 24 | $2.4M | $743.0K |
| Q4 25 | $-3.1M | — | ||
| Q3 25 | $-5.1M | $-4.7M | ||
| Q2 25 | $-4.1M | $-1.8M | ||
| Q1 25 | $-2.7M | $-1.7M | ||
| Q4 24 | $-3.0M | $586.4K | ||
| Q3 24 | $-2.0M | $-1.6M | ||
| Q2 24 | $-2.1M | $-934.3K | ||
| Q1 24 | $-2.0M | $-545.7K |
| Q4 25 | — | — | ||
| Q3 25 | — | -20.1% | ||
| Q2 25 | — | 53.5% | ||
| Q1 25 | — | 49.8% | ||
| Q4 24 | — | 13.3% | ||
| Q3 24 | — | 85.0% | ||
| Q2 24 | — | 50.6% | ||
| Q1 24 | — | 51.9% |
| Q4 25 | -196.9% | — | ||
| Q3 25 | -158.6% | -350.0% | ||
| Q2 25 | -198.2% | -37.0% | ||
| Q1 25 | -141.7% | -68.7% | ||
| Q4 24 | -133.5% | -255.1% | ||
| Q3 24 | -84.0% | -238.0% | ||
| Q2 24 | -87.1% | -149.4% | ||
| Q1 24 | -80.8% | -73.8% |
| Q4 25 | -197.0% | — | ||
| Q3 25 | -349.3% | -506.4% | ||
| Q2 25 | -319.9% | -68.3% | ||
| Q1 25 | -143.5% | -73.4% | ||
| Q4 24 | -134.4% | 45.7% | ||
| Q3 24 | -85.1% | -226.8% | ||
| Q2 24 | -88.0% | -149.9% | ||
| Q1 24 | -81.5% | -73.4% |
| Q4 25 | $-3.59 | — | ||
| Q3 25 | $-4.74 | $-0.27 | ||
| Q2 25 | $-0.17 | $-0.12 | ||
| Q1 25 | $-0.16 | $-0.12 | ||
| Q4 24 | $-17.27 | $0.06 | ||
| Q3 24 | $-4.84 | $-0.13 | ||
| Q2 24 | $-0.19 | $-0.09 | ||
| Q1 24 | $-0.20 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.4M | $3.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $7.3M | $4.1M |
| Total Assets | $11.0M | $17.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.4M | — | ||
| Q3 25 | $7.7M | $3.6M | ||
| Q2 25 | $802.8K | $78.5K | ||
| Q1 25 | $444.7K | $179.1K | ||
| Q4 24 | $1.1M | $533.9K | ||
| Q3 24 | $756.6K | $2.1M | ||
| Q2 24 | $801.3K | $2.7M | ||
| Q1 24 | $2.5M | $5.2M |
| Q4 25 | $7.3M | — | ||
| Q3 25 | $8.9M | $4.1M | ||
| Q2 25 | $-2.1M | $4.3M | ||
| Q1 25 | $1.4M | $6.8M | ||
| Q4 24 | $2.6M | $10.2M | ||
| Q3 24 | $3.1M | $9.7M | ||
| Q2 24 | $3.4M | $10.3M | ||
| Q1 24 | $5.3M | $12.4M |
| Q4 25 | $11.0M | — | ||
| Q3 25 | $11.5M | $17.5M | ||
| Q2 25 | $4.8M | $14.9M | ||
| Q1 25 | $5.5M | $16.0M | ||
| Q4 24 | $6.5M | $17.2M | ||
| Q3 24 | $6.6M | $10.6M | ||
| Q2 24 | $6.7M | $11.1M | ||
| Q1 24 | $8.0M | $13.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-2.6M | $763.1K |
| Free Cash FlowOCF − Capex | $-2.6M | — |
| FCF MarginFCF / Revenue | -160.7% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.6M | — | ||
| Q3 25 | $-2.5M | $763.1K | ||
| Q2 25 | $-2.6M | $-1.0M | ||
| Q1 25 | $-1.6M | $-1.2M | ||
| Q4 24 | $-1.7M | $-6.5M | ||
| Q3 24 | $-1.7M | $632.7K | ||
| Q2 24 | $-1.5M | $-2.4M | ||
| Q1 24 | $-2.3M | $-866.3K |
| Q4 25 | $-2.6M | — | ||
| Q3 25 | $-2.5M | — | ||
| Q2 25 | $-2.7M | — | ||
| Q1 25 | $-1.7M | — | ||
| Q4 24 | $-1.7M | — | ||
| Q3 24 | $-1.7M | $589.6K | ||
| Q2 24 | $-1.6M | $-2.4M | ||
| Q1 24 | $-2.4M | $-1.0M |
| Q4 25 | -160.7% | — | ||
| Q3 25 | -171.8% | — | ||
| Q2 25 | -209.6% | — | ||
| Q1 25 | -91.3% | — | ||
| Q4 24 | -76.0% | — | ||
| Q3 24 | -73.1% | 82.3% | ||
| Q2 24 | -65.1% | -388.0% | ||
| Q1 24 | -99.2% | -136.9% |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 2.7% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.4% | 6.0% | ||
| Q2 24 | 1.2% | 5.1% | ||
| Q1 24 | 1.7% | 20.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -11.11× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.